"The antioxidant glutathione peroxidase family and spermatozoa: a complex story"
GLP-1 receptor agonists such as semaglutide (Ozempic, Wegovy), dulaglutide (Trulicity), and liraglutide (Victoza, Saxenda) are increasingly prescribed for type 2 diabetes and weight management in the UK
Weight Loss Medication Timeline for 2026 December 22, 2025 The FDA approved oral Wegovy, also known as semaglutide 25 mg
Semaglutide is approved as Ozempic (diabetes, December 2017), Wegovy (obesity, June 2021), and, in oral form, the Ozempic pill (diabetes, 2026, which reformulated and renamed Rybelsus) and the Wegovy pill (weight, December 2025)
Beyond satiety, this signaling appears to be a key factor for neuroprotection (160) insulin sensitivity and glucose metabolism (158)